Welcome to our dedicated page for Jabil news (Ticker: JBL), a resource for investors and traders seeking the latest updates and insights on Jabil stock.
Jabil Inc (NYSE: JBL) is a global leader in electronics manufacturing services and engineering solutions, serving industries from healthcare to cloud infrastructure. This news hub provides investors and professionals with timely updates on corporate developments shaping the manufacturing sector.
Access official press releases, financial reports, and strategic announcements in one centralized location. Track Jabil's operational milestones including supply chain innovations, technology partnerships, and manufacturing expansions that demonstrate its market leadership.
Our curated news collection covers essential updates such as quarterly earnings disclosures, product launch announcements, and sustainability initiatives. Stay informed about Jabil's advancements in material sciences, AI-driven production solutions, and global capacity enhancements.
Bookmark this page for streamlined access to verified information about Jabil's business trajectory. Combine strategic insights with operational data to inform your analysis of this manufacturing solutions provider.
Jabil (NYSE: JBL) has announced the appointment of Sujatha Chandrasekaran to its Board of Directors. Chandrasekaran brings significant experience from leadership roles in healthcare, retail, consumer, supply chain, and manufacturing sectors, managing businesses with revenues from $3B to $500B.
Most recently, she served as Senior Executive Vice President, Chief Digital and Information Officer at CommonSpirit Health, the second-largest nonprofit hospital system in the U.S. Her previous roles include Global Chief Digital and Information Officer at Kimberly-Clark and Global Chief Technology and Data Officer at Walmart.
Chandrasekaran currently serves on the boards of American Eagle Outfitters, Brenntag SE, ATOS SE, Agendia, and Pando.AI. She is also the founder of the T200 Foundation, focusing on fostering women's growth in technology.
Jabil (NYSE: JBL) has announced a quarterly dividend payment of $0.08 per share of common stock. The dividend will be paid on June 3, 2025, to shareholders of record as of May 15, 2025. The company highlighted its consistent track record of paying quarterly cash dividends, which dates back to May 15, 2006, demonstrating a long-standing commitment to returning value to shareholders.
Jabil (NYSE: JBL) has launched new 1.6T transceivers capable of transmitting data at speeds up to 1.6 Terabits per second, designed to meet growing demand for AI/ML workloads, high-performance computing, and data center connectivity.
The transceivers, built using Intel® Silicon Photonics engine, can achieve 200 Gigabits per lane on both electrical and optical interfaces. Available in DR8, DR8+, and 2xFR4 variants, they can double bandwidth capacity of data center racks without infrastructure modifications while maintaining low power consumption.
The company will showcase the new technology at the 2025 OFC Conference in San Francisco, where demos will be available by appointment at booth 5845.
Jabil (NYSE: JBL) reported strong second quarter fiscal 2025 results, with net revenue reaching $6.7 billion. The company posted U.S. GAAP operating income of $245 million and diluted earnings per share of $1.06. On a Non-GAAP basis, core operating income was $334 million with core diluted earnings per share of $1.94.
CEO Mike Dastoor highlighted exceptional year-to-date performance, noting strength in capital equipment, cloud and data center infrastructure, and digital commerce end-markets. The company's position as a U.S. domiciled manufacturing service provider with significant U.S. footprint was emphasized as increasingly valuable amid evolving geopolitical situations.
Jabil (NYSE: JBL) will release its second quarter of fiscal year 2025 financials on Thursday, March 20, 2025, before market opens.
The company will host a conference call and webcast to review the results on the same day at 8:30 a.m. ET. U.S. participants can dial in at (877) 407-6184, while international participants can use (201) 389-0877. The live audio webcast and accompanying slide presentation will be accessible via the Investor Relations section of Jabil’s website.
An archived replay of the webcast will be available after the call.
Jabil Inc. (NYSE: JBL) has announced plans to establish its second factory in Gujarat, India, following a Memorandum of Understanding (MoU) signed in November 2024. The company, which operates over 100 sites across 25+ countries, will explore building a post-wafer fabrication silicon photonics facility with advanced co-packaged optics capabilities.
The announcement was made during the Gujarat SemiConnect IESA Vision Summit in Gandhinagar, with Gujarat Chief Minister Bhupendra Patel present. The expansion aims to create jobs and boost domestic semiconductor industry development through Jabil's photonics expertise.
Jabil brings over a decade of experience in photonics, specializing in designing devices and systems, developing amplifiers, transceivers, laser packages, and optical networking products. The company serves diverse industries including semiconductor equipment, data centers, automotive, healthcare, and warehouse automation.
Jabil (NYSE: JBL) has released its fiscal year 2024 Sustainability Progress Report, showcasing significant environmental achievements. The company has reduced enterprise-wide greenhouse gas emissions by 46% compared to its 2019 baseline, positioning it to exceed its 50% reduction target by 2030.
Key highlights include:
- 10% of applicable sites achieving 90% or more landfill diversion
- Over 589,000 volunteer hours completed in local communities during 2024
- Expanded Scope 3 indirect GHG emission inventory
- Joined the Circular Electronics Partnership (CEP)
- Acquired Mikros Technologies for energy-efficient cooling solutions
The report aligns with global standards including GRI, SASB, and TCFD, demonstrating Jabil's commitment to environmental and social responsibility. Strategic partnerships with companies like Thermo Fisher Scientific and Ocado reinforce their dedication to sustainability and supporting customer environmental goals.
Apptronik and Jabil (NYSE: JBL) have announced a strategic collaboration to build Apollo humanoid robots and integrate them into Jabil's manufacturing operations. This partnership aims to create a system where Apollo robots can eventually build more Apollo robots.
As part of the pilot program, newly manufactured Apollo units will undergo real-world validation testing in Jabil's factory environment, performing tasks like inspection, sorting, kitting, and sub-assembly before deployment to Apptronik customers. The humanoids are designed to augment the existing workforce, allowing employees to focus on more creative, thought-intensive projects.
Jabil will serve as the worldwide manufacturing partner for Apollo robots, providing Apptronik with flexibility to scale production globally. Apptronik's design includes unique actuators that require fewer components, less manufacturing time, and lower costs compared to previous generations, making mass production more feasible.
The collaboration aims to make general-purpose humanoids more affordable for expansion into new markets including retail, elder care, and eventually home use.
Pharmaceutics International, Inc. (Pii) has been acquired by Jabil Inc. (NYSE: JBL) in an all-cash transaction for an undisclosed amount. The sale marks the exit of a consortium of investors including Signet Healthcare Partners, Athyrium Capital Management, Hildred Capital, and Pharmascience Inc.
Pii, based in Hunt Valley, Maryland, is a contract development and manufacturing organization specializing in aseptic and sterile injectable pharmaceutical products. The company has provided development and manufacturing services for both NDA and aNDA products for nearly three decades, offering formulation capabilities across virtually all dosage forms and specializing in complex formulations.
The company operates on both a fee-for-service basis for pharmaceutical clients and a profit-share or royalty basis for marketing partners.
Jabil (NYSE: JBL) has successfully acquired Pharmaceutics International, Inc. (Pii), a contract development and manufacturing organization (CDMO), on February 3, 2025. Pii's facilities in Hunt Valley, Maryland, span over 360,000 square feet across four sites, featuring over 70 manufacturing rooms specializing in aseptic filling, oral solid dose production, and handling high potency compounds.
The acquisition enhances Jabil's Pharmaceutical Solutions portfolio by adding Pii's capabilities in drug development, clinical trials, and product commercialization. Pii brings expertise in aseptic filling, lyophilization, and oral solid dose manufacturing, complementing Jabil's existing strengths in parenteral drug delivery systems like auto-injectors and inhalers.
Through this acquisition, Pii gains access to Jabil's global infrastructure, automation capabilities, and supply chain efficiencies, while Jabil expands its pharmaceutical manufacturing capabilities and enters the CDMO market.
